Prognostic Factors and Survival Outcomes in Marginal Zone Lymphoma: Real-Life Experience
Marginal zone lymphoma (MZL) is typically an indolent malignancy, though some patients may exhibit aggressive disease. In addition to lymphocytosis, MZL should be considered in cases with lymphopaenia or monoclonal gammopathy. Advanced age, elevated LDH, high IPI scores, and advanced stage have been linked to poorer survival outcomes. These findings underline the prognostic heterogeneity among MZL subtypes.
Authors
- Şerife Emre Ünsal (ORCID: https://orcid.org/0000-0003-4581-8722)
- Neslihan Mandacı Şanlı
Institutions
- Erciyes University (TR)
Publication Details
- Journal
- Turkish Journal of Hematology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.4274/tjh.galenos.2026.82787
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00